Back
American Express Vs. Akero Therapeutics Industry Stock Comparison
Buy
69
AXP
American Express
Last Price:
$308.56
Seasonality Move:
0.56%
Buy
53
AKRO
Akero Therapeutics
Last Price:
$55.05
Seasonality Move:
30.3%
Buy
69
American Express (AXP)
is a Buy
Is American Express a Buy, Sell or Hold?
-
The current American Express [AXP] share price is $308.59. The Score for AXP is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
AXP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $55.04. The Score for AKRO is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AXP Stock Price Chart
What is American Express's stock price today?
-
The American Express share price today is $308.59Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AXP is experiencing slight selling pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $55.04Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
AXP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.4 | Buy |
Relative Strength Index (14 RSI): | 65.7 | Buy |
Chaikin Money Flow: | -522614 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (290.37 - 301.85) | Buy |
Bollinger Bands (100): | (262.14 - 304.8) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.47 | Buy |
Relative Strength Index (14 RSI): | 64.86 | Buy |
Chaikin Money Flow: | 663430 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (48.63 - 55.25) | Buy |
Bollinger Bands (100): | (40.1 - 52.3) | Buy |
AXP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 298.3 | Buy |
20-day SMA: | 297.72 | Buy |
50-day SMA: | 284.98 | Buy |
200-day SMA: | 285.35 | Buy |
8-day EMA: | 301.43 | Buy |
20-day EMA: | 297.32 | Buy |
50-day EMA: | 289.78 | Buy |
200-day EMA: | 277.31 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.86 | Buy |
20-day SMA: | 53.06 | Buy |
50-day SMA: | 46.33 | Buy |
200-day SMA: | 37.77 | Buy |
8-day EMA: | 54.4 | Buy |
20-day EMA: | 52.52 | Buy |
50-day EMA: | 48.38 | Buy |
200-day EMA: | 39.65 | Buy |
American Express Earnings Growth & AXP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.76 per share, an increase next quarter of $0.39 per share, an increase this year of $1.66 per share, and an increase next year of $2.12 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and a decrease next year of $0.72 per share.
American Express Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |